Search Results 961-970 of 10312 for total t4

  1. Soft tissue sarcoma - Doctors and departments - Mayo Clinic

    ... total knee replacement, Knee arthritis, Failed total hip replacement, Soft tissue tumor, Pelvic sarcoma, Periprosthetic joint infection. Show more areas of ...

  2. Real-Time Myocardial Perfusion Echocardiography in the ICU - Mayo Clinic

    Experienced sonographer available to complete RTMPE portion of the exam; Provider willing to complete the study survey. Exclusion Criteria: Adults < 18 years ...

  3. A Study to Evaluate M7824 with Concurrent Chemoradiation (cCRT) in Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) - Mayo Clinic

    If a pleural effusion is present, the following criteria must be met to exclude malignant involvement (incurable T4 disease):. When pleural fluid is visible ...

  4. Lisaftoclax (APG-2575) Combined With Azacytidine (AZA) In The Treatment Of Patients With Higher-risk Myelodysplastic Syndrome (GLORA-4). - Mayo Clinic

    About this study. A global multicenter, randomized, double-blind, placebo-controlled, pivotal phase III study. To evaluate overall survival (OS) of ...

  5. A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy - Mayo Clinic

    This applies even if the subject practices complete and continued sexual abstinence. ... Serum total bilirubin >2.0 mg/dL (with the exception of Gilbert's ...

  6. Cardiovascular Medicine - Clinical trials

    ... complete or partial remission. A standard treatment is considered not well tolerated if the patient experiences severe side effects without providing an ...

  7. Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007) - Mayo Clinic

    The primary objective of the study is to compare sacituzumab tirumotecan combined with pembrolizumab to pembrolizumab alone with respect to overall survival (OS) ...

  8. Simulated teleneonatology consult - Mayo Clinic

    An error occurred, please try again later. Copy for customer care: session ID undefined. Try again. Share · Tweet . VID-20442918.

  9. Stomach Cancer Clinical Trials - Mayo Clinic Research

    The purpose of this study is to determine if Regorafenib improves overall survival in refractory AGEC A randomized phase III, double-blind, placebo-controlled ...

  10. Cardiovascular Medicine - Clinical trials

    ... complete four study visits. Your first two study visits as described above will be completed at the beginning of cardiac rehabilitation and then we will ask ...